HOME » About Us » Leadership Team » Management Team

    Management Team

     

    Venkateswarlu (Venkat) Nelabhotla, CEO & Board Member

    Venkat comes with a very rich and global experience of more than 25 years, successfully leading organizations in the biotech and cosmoceutics businesses. He held top management roles in the biotech and pharmaceutical companies like Shantha Biotechnics (A Sanofi Company) and Aurobindo Pharma and he immensely contributed to their all-round growth. He was instrumental in creating market focus and orchestrating vaccine portfolio strategy in Shantha Biotech - a biosimilar and vaccine company, and it was eventually acquired by Sanofi for $800 million USD. He has been a part of significant revenue growth and value creation in Aurobindo Pharma in the global business segment of APIs and finished dosage form products in multiple therapy areas.

    He has held CEO and President roles in Emami and Cavinkare, cosmoceutical and consumer product companies in India with global operations, creating value and growing them significantly with an all rounded approach. During his stint at Emami (a listed company) as CEO, the company's market cap increased from $ 300 MN to $ 1.2 BN. During the early part of his career, he created some very successful Cosmoceutical brands in Cavinkare, and built the organization with a 10X revenue increase in 6 years’ time.

    He comes with core strengths in Strategy, Innovation, Technology, Commercialization, Organization building, Finance, M&A. Venkat has received his B.Tech in Mechanical Engineering and an MBA from Indian Institute of Management – Ahmedabad, India.

    Contact information: nvenkat@vyometx.com

     

    Dr. Angelo Secci, Chief Medical Officer

    Dr. Angelo Secci is a seasoned clinical research and development professional with over two decades of experience. His experience in various therapeutic areas such as Dermatology, Female Health Care, Cardiovascular, Imaging, Cancer Pain, Gastro Intestinal, and others allow him to comfortably understand and approach the many aspects of drug development. Throughout the years he has worked for the full spectrum of pharmaceutical companies; from large global companies like Warner Lambert/Pfizer, Schering AG/Bayer, Otsuka, and GSK to medium and small biotechnology companies like Alliance, and Eurand and covered various roles ranging from Associate Director to Vice President of Clinical Development and Operations.
     
    Angelo received his degree in medicine from the University or Rome (Italy) and has practiced medicine for a short period of time as Vascular Surgeon before starting his research activities in the United States at UCLA. He has also invented and co-invented products in the medical field (medicines and devices).

     

    Charles G. Chavdarian, Ph.D.

    Dr. Charles G. Chavdarian is an industry consultant specializing in Pharmaceutical Research & Development, Analytical R&D, Formulation/Manufacturing, QA/QC, and Regulatory CMC.  He was formerly the Executive Director of Analytical Sciences & Regulatory CMC at Dow Pharmaceutical Sciences, Inc., Petaluma, California.  He held earlier management positions at Syntex Corp., Penederm Inc., ALZA Corp., Cellegy Pharmaceuticals, and InSite Vision.  He has worked in the pharmaceutical industry for over 30 years, and earlier in the chemical industry.  His pharmaceutical expertise spans nearly every dosage form including solid oral, parenteral, topical (dermatological and ophthalmic), and transdermal, and also includes commercial Rx, OTC, and personal care products.  Dr. Chavdarian received his B.S. degree in Chemistry from the University of Michigan, Ann Arbor, and his Ph.D. degree in Organic Chemistry from the University of California, Berkeley, followed by a postdoctoral appointment in Pharmaceutical Chemistry at the University of California, San Francisco Medical Center.  He is the author of over 35 technical publications and patents. His strong technical background includes organic and analytical chemistry, analytical method development and validation, formulation development and manufacturing support (APIs and drug products), technology transfer, bioanalytical studies, quality control testing, stability testing, management of stability facilities and studies, and QA auditing of GMP laboratories and manufacturing facilities.  He has also worked as a project manager and as a business development representative with client companies, and has performed due diligence audits/inspections.  Dr. Chavdarian has extensive experience with regulatory CMC where he has led technical teams involved in the design and implementation of Phase 1 through 4 stability programs, and the compilation and authorship of drug substance and drug product CMC sections for regulatory submissions (i.e., e-CTDs), both domestically and internationally (IND, NDA, ANDA, NDS, CTA, IMPD, MAA). In addition, Dr. Chavdarian has interacted first-hand with regulatory agencies (FDA, Health Canada, Europe) on many occasions (pre-Phase 1 and Phase1 – Phase 3 Guidance meetings, Pre-Approval Inspections), and has successfully worked on many approved drug applications – e.g., NDA, NDS, and ANDA submissions.  Dr. Chavdarian has been a speaker at several technical workshops and conferences, including a national webinar on topical drug product development.
     

    Dr. Rena Patel, Chief Patent Counsel

    Dr. Rena Patel is a seasoned IP attorney and has been in practice since 1998. She is a graduate of Duquesne University (Ph.D.) and California Western School of Law (J.D.). She started her law career as an associate at Woodcock Washburn (now Baker Hostetler), progressing to Patent Counsel at Bristol-Myers Squibb Company, and Chief Patent Counsel – Oral Care at Colgate-Palmolive Company.

    Rena has significant global experience in IP practice having also been an independent consultant working with start-up ventures and multinational pharmaceutical companies in Europe and Asia. Rena has a strong interest in education and serves as the vice-president of the West Windsor-Plainsboro Education Foundation, which is a private, non-profit organization that supports excellence in the WW-P Regional Schools through innovative programs, strategic initiatives, and funding of grants for teachers.

    Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.